Right Internal Carotid Artery and Basilar Artery Aneurysms After New Coronavirus Infection COVID-19 in Adolescent: Clinical Case
https://doi.org/10.15690/pf.v18i5.2329
Abstract
The number of people infected with the SARS-CoV-2 virus causing COVID-19 is steadily growing around the world. Given the fact that the disease is new, it is necessary to study the characteristics of its spreading and clinical course, including pediatric population. The article presents clinical case of COVID-19 in 15-year-old child with the development of thrombosed basilar artery aneurysm that compressed the brain stem in the pons and subarachnoid hemorrhage, the development of a fusiform aneurysm of the right internal carotid artery. These pathologies were later complicated by right-sided hemiparesis. The importance of inter-clinical interaction of physicians of all specialties
and the need for early rehabilitation at the outpatient stage of treatment in the context of the COVID-19 pandemic were shown.
About the Authors
Dina S. RusinovaRussian Federation
Dina S. Rusinova
5а Smolnaya Str., 125445, Moscow, +7 (499) 638-30-69
Disclosure of interest:
Not declared
Mikhail A. Martakov
Russian Federation
Mikhail A. Martakov
5а Smolnaya Str., 125445, Moscow, +7 (499) 638-30-69
Disclosure of interest:
Not declared
Soslan B. Medoev
Russian Federation
Soslan B. Medoev
28, Geroev Panfilovcev Str., 125373 Moscow, +7 (495) 496-91-00
Disclosure of interest:
Not declared
Ludmila V. Ryzhuk
Russian Federation
ludmila V. Ryzhuk
5а Smolnaya Str., 125445, Moscow, +7 (499) 638-30-69
Disclosure of interest:
Not declared
Vyacheslav V. Yazev
Russian Federation
Vyacheslav V. Yazev
5а Smolnaya Str., 125445, Moscow, +7 (499) 638-30-69
Disclosure of interest:
Not declared
References
1. Namazova-Baranova LS. Coronaviral Infection (COVID-19) in Children (Situation on April 2020). Pediatricheskaya farmakologiya — Pediatric pharmacology. 2020;17(2):85–94. (In Russ). doi: 10.15690/pf.v17i2.2094
2. Намазова-Баранова Л.С., Баранов А.А. Коронавирусная инфекция (COVID-19) у детей (состояние на июнь 2020) // Педиатрическая фармакология. — 2020. — Т. 17. — № 3. — С. 162–178. [Namazova-Baranova LS, Baranov AA. Coronaviral Infection (COVID-19) in Children (Situation on June 2020). Pediatricheskaya farmakologiya — Pediatric pharmacology. 2020;17(3):162–178. (In Russ).] doi: 10.15690/pf.v17i3.2121
3. Rusinova DS, Nikonov EL, Namazva-Baranova LS, et al. Primary Observational Results on Children Who Have Been Exposed to COVID-19 in Moscow. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2020;17(2):95–102. (In Russ). doi: 10.15690/pf.v17i2.2095
4. Alexandrovich YuS, Baybarina EN, Baranov AA, et al. Management of Children with Disease Caused by New Coronaviral Infection (SARS-CoV-2). Pediatricheskaya farmakologiya — Pediatric pharmacology. 2020;17(2):103–118. (In Russ). doi: 10.15690/pf.v17i2.2096
5. Jiang S, Shi Z, Shu Y, et al. A distinct name is needed for the new coronavirus. Lancet. 2020;395(10228):949. doi: 10.1016/S0140-6736(20)30419-0
6. Melekhina EV, Gorelov AV, Muzyka AD. Clinical characteistics of COVID-19 in children of different ages. Literature review as of April 2020. Voprosy prakticheskoi pediatrii = Clinical Practice in Pediatrics. 2020;15(2):7–20. (In Russ). doi: 10.20953/1817-7646-2020-2-7-20
7. Uskov AN, Lobzin YuV, Rychkova SV, et al. Course of a new coronavirus infection in children: some aspects of monitoring and analysis of mortality. Zhurnal infectologii = Journal of Infectology. 2020;12(3):12–20. (In Russ). doi: 10.22625/2072-6732-2020-12-3-12-20
8. Kaleda MI, Nikishina IP, Fedorov ES, Nasonov EL. Coronavirus Disease 2019 (COVID-19) in Children: Lessons from Pediatric Rheumatology. Nauchcno-Practicheskaya Revmatologia = Rheumatology Science and Practice. 2020;58(5):469–479. (In Russ). doi: 10.47360/1995-4484-2020-469-479
9. Kubanov AA, Deryabin DG. A New Look at the COVID-19 Pathogenesis: the Disease is a Generalized Viral Vasculitis, and the Lung Tissue Damage is a Variant of Angiogenic Pulmonary Edema. Vestnik RAMN = Annals of the Russian Academy of Medical Sciences. 2020;75(2):115–117. (In Russ). doi: 10.15690/vramn1347
10. Cascella M, Rajnik M, Cuomo A, et al. Features, evaluation and treatment coronavirus (COVID-19). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. Avalable online: https://www.ncbi.nlm.nih.gov/books/NBK554776. Accessed on November 3, 2021.
11. Yi Y, Lagniton PN, Ye S, et al. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci. 2020;16(10):1753–1766. doi: 10.7150/ijbs.45134
12. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234): 1417–1418. doi: 10.1016/S0140-6736(20)30937-5
13. Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020;58(7):1116–1120. Mar 16. doi: 10.1515/cclm-2020-0188
14. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847. doi: 10.1111/jth.14768
15. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020;506:145–148. doi: 10.1016/j.cca.2020.03.022
Review
For citations:
Rusinova D.S., Martakov M.A., Medoev S.B., Ryzhuk L.V., Yazev V.V. Right Internal Carotid Artery and Basilar Artery Aneurysms After New Coronavirus Infection COVID-19 in Adolescent: Clinical Case. Pediatric pharmacology. 2021;18(5):385-391. (In Russ.) https://doi.org/10.15690/pf.v18i5.2329